Cardiovascular research
-
Cardiovascular research · Mar 2016
Corrigendum to: miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE-/- mice.
[Cardiovasc Res 2015; 106(1):131–142] There were some references to the reported concentration of a standard reagent used which were incorrect. This does not affect the conclusion of the paper in any way but the author would like to amend this. ⋯ In Figure 4 the legend, 500 mg/ml should be substituted with 500 ng/ml. In section 3.8 IGF2 recombinant protein rescues miR-30e-repressed osteogenesis in SMCs there are two unit errors; one is 500 mg/ml should be corrected to 500 ng/ml; the second is 250 mg/ml should be corrected to 250 ng/ml.